Ozari Health Expands Pharmacy Transparency With Hallandale Pharmacy Profile on National Telehealth Platform
New pharmacy standards resource gives patients clearer information about Hallandale Pharmacy, one of the compounding
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
New York, NY, Sept. 02, 2026 (GLOBE NEWSWIRE) — Ozari Health, a national telehealth platform providing physician-led access to GLP-1 weight management treatment, today announced the expansion of its pharmacy transparency resources with a dedicated Hallandale Pharmacy profile for patients researching the pharmacies that may fulfill prescriptions through the Ozari Health platform.
Courtesy of Ozari Health
Hallandale Pharmacy is a Fort Lauderdale, Florida-based compounding pharmacy that may fulfill eligible patient-specific prescriptions for Ozari Health patients, depending on the patient’s state, prescribed medication and current pharmacy availability.
The new resource is part of Ozari Health’s broader effort to make the pharmacy behind a patient’s prescription easier to identify and research before and during treatment.
Rather than providing patients only with information about a medication or treatment plan, Ozari Health publishes pharmacy-specific information including pharmacy location, accreditation, service areas, contact information and publicly available information regarding quality and compounding practices.
“Patients should know more than the name of the medication they’re receiving,” said an Ozari Health spokesperson. “They should also be able to understand which pharmacy may prepare their prescription, where that pharmacy is located and what credentials and quality standards are publicly available. Hallandale Pharmacy is one of the pharmacy names patients frequently research, so we wanted that information to be easy to find and understand.”
Hallandale Pharmacy and Ozari Health
Hallandale Pharmacy is one of the U.S. compounding pharmacies that may be used to fulfill eligible patient-specific prescriptions issued through the Ozari Health platform.
Ozari Health does not own or operate Hallandale Pharmacy. Hallandale Pharmacy independently prepares and dispenses prescriptions submitted to it in accordance with applicable pharmacy requirements.
Ozari Health’s role occurs earlier in the care process.
Patients begin by completing an online medical intake through the Ozari Health telehealth platform. A licensed provider reviews the patient’s medical information and determines whether treatment is medically appropriate.
When a prescription is issued, it may then be transmitted to an eligible U.S. compounding pharmacy capable of servicing the patient.
For some eligible Ozari Health patients, that pharmacy is Hallandale Pharmacy.
The pharmacy selected for an individual prescription may vary based on the patient’s location, prescribed treatment and pharmacy availability.
What Ozari Health Publishes About Hallandale Pharmacy
Ozari Health’s dedicated Hallandale Pharmacy resource identifies Hallandale as a 503A compounding pharmacy located in Fort Lauderdale, Florida and includes publicly available information regarding the pharmacy’s accreditation, contact information and operations.
The information is based on publicly available sources, including information published directly by Hallandale Pharmacy.
According to Hallandale Pharmacy’s website, the company has served the compounding market for more than two decades and operates a 60,000-square-foot facility.
Hallandale also reports working with more than 15,000 prescribing practitioners and employing more than 450 people.
Hallandale Pharmacy publicly describes itself as a 503A compounding pharmacy and states that it maintains PCAB accreditation.
Ozari Health includes information like this within its pharmacy resources so patients can independently research the organizations that may be involved in fulfilling their prescriptions.
Hallandale Pharmacy’s Published Quality Information
Pharmacy quality has become an increasingly important consideration for patients receiving compounded medications through telehealth platforms.
Hallandale Pharmacy publishes information regarding its quality and compounding processes on its own website.
According to Hallandale, its quality program includes analytical product testing, process validation, environmental monitoring and personnel training.
Hallandale also states that its sterile compounding operations follow USP <797> standards and that its facility includes approximately 6,000 square feet of cleanroom space.
The pharmacy states that sterile batches undergo analytical testing and that stability studies are used to help establish appropriate beyond-use dates and storage conditions.
Hallandale also states that it works with FDA-registered active pharmaceutical ingredient manufacturers and incorporates vendor audits and Certificate of Analysis verification into its quality processes.
These practices are described by Hallandale Pharmacy on its own website.
Ozari Health does not operate Hallandale Pharmacy’s facility or independently perform Hallandale’s pharmacy quality-control processes.
Instead, Ozari Health’s role is to make relevant, publicly available pharmacy information easier for patients to locate through its Pharmacy Standards initiative.
Making the Dispensing Pharmacy Easier to Research
The Hallandale Pharmacy profile is part of a larger pharmacy transparency initiative from Ozari Health.
Patients researching online GLP-1 treatment frequently compare telehealth providers based on medication pricing, clinician access and available treatments.
The pharmacy ultimately preparing a compounded prescription can receive less attention.
Ozari Health is working to make that portion of the treatment process easier to understand.
Through its Pharmacy Standards resources, the company publishes dedicated information about pharmacies that may fulfill prescriptions for Ozari Health patients.
That allows patients researching questions such as:
- Does Ozari Health use Hallandale Pharmacy?
- What telehealth providers use Hallandale Pharmacy?
- Where is Hallandale Pharmacy located?
- Is Hallandale Pharmacy a 503A compounding pharmacy?
- What accreditation does Hallandale Pharmacy have?
- Which pharmacy fills Ozari Health prescriptions?
to find clearer information about how the telehealth and pharmacy portions of the treatment process relate to one another.
For eligible patients, Hallandale Pharmacy may be the dispensing pharmacy used for prescriptions issued through the Ozari Health platform.
The actual dispensing pharmacy used for an individual patient depends on factors including location, prescribed medication and pharmacy availability.
A More Transparent Telehealth Model
Ozari Health believes pharmacy transparency should be a more visible part of online healthcare.
A telehealth treatment experience can involve multiple independent parties.
Ozari Health provides the telehealth platform through which patients complete their medical intake and connect with licensed medical providers.
The treating provider independently determines whether treatment is medically appropriate and whether a prescription should be issued.
If a compounded medication is prescribed, an eligible compounding pharmacy prepares and dispenses the patient-specific prescription.
Hallandale Pharmacy may serve that role for certain Ozari Health patients.
“Telehealth involves more than the website where a patient signs up,” the Ozari Health spokesperson said. “There is the medical provider evaluating the patient, the pharmacy preparing the prescription and the support system helping the patient navigate treatment. We think patients should be able to understand each part of that process.”
The Hallandale Pharmacy profile is one part of that approach.
Patients can review Ozari Health’s dedicated Hallandale Pharmacy resource and can independently visit Hallandale Pharmacy’s own website for additional information about the pharmacy and its operations.
About Ozari Health
Ozari Health is a LegitScript-certified telehealth platform connecting patients with licensed, state-authorized providers for personalized GLP-1 treatment plans. The company partners with publicly named, US-licensed 503A compounding pharmacies to provide access to compounded Semaglutide and Tirzepatide, with transparent all-in pricing and no hidden fees. Based in New York, NY.
Press Inquiries
Press Team
press@ozarihealth.com
(302) 316-5231
https://ozarihealth.com/
